Estrella Immunopharma, Inc. (ESLA): debt financing — TradeUP Acquisition Corp. extends business combination deadline to August 19, 2023 via $37,433 deposit by Estrella

Estrella Immunopharma, Inc.

TradeUP extends deadline to complete initial business combination by one month to August 19, 2023.
Estrella deposited $37,432.70 ($0.05 per remaining share) into trust account for the extension.
Deposit funded by unsecured promissory note from TradeUP to Estrella, convertible into shares at $10.00.
Company may continue monthly extensions up to July 14, 2024.

item 1.01 item 2.03 item 3.02 item 8.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

Estrella Immunopharma, Inc. incurred convertible notes of $37,432.70 with Estrella Biopharma, Inc. at bears no interest maturing upon the consummation of the Company’s business combination.

Instrument: convertible notes
Principal: $37,432.70
Counterparty: Estrella Biopharma, Inc.
Rate: bears no interest
Maturity: upon the consummation of the Company’s business combination
Event: incurrence

Exact text from the filing

Such deposit is evidenced by an unsecured promissory note in the principal amount of $37,432.70 issued by the Company to Estrella (the “Extension Note”). The Extension Note bears no interest and is payable in full upon the consummation of the Company’s business combination (the “Business Combination”) (such date, the “Maturity Date”).

View on SEC.gov

Browse all debt financings →

Estrella Immunopharma, Inc. filing history →

Source: SEC EDGAR

accession 0001213900-23-058025

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.